8
100%(KDOQItarget)
HD pts with
URR ≥65%
CAPDpts with
deliveredKt/V ≥1.7
Incident ptsw/AV fistula
at 1st OPdialysis
100%(KDOQItarget)
50%(KDOQItarget)
94%(2010)
DM ptswith 4+
A1c tests
ESRD ptswith oneflu vacc.
DM ptswith 2+
lipid tests
65.4%(2010)
DM pts with comp
DM mon.
51.6%(2010)
90%(HP2020target)
Dialysis adequacy Vascular access Diabetic care Vaccinations90% 90% 90%
15% (M.E .form
2010)87.1%(2008)
58.8%(2010)
17.2%(2010)
91 92 93 94 95 96 97 98 99 00 01 02 03 04 05 06 07 08 09 10
Perc
ent o
f pat
ient
s
0
20
40
60
80
100
<10
>12
10-12
91 92 93 94 95 96 97 98 99 00 01 02 03 04 05 06 07 08 0910
Mean wee
kly EP
O dose (1
,000
s of
units)
5
10
15
20
Hem
oglo
bin (g/d
l)
9
10
11
12
EPO
Hemoglobin
Months after initiation
1 2 3 4 5 6
Hem
oglobi
n (g
/dl)
8
9
10
11
12
13
1998 2002 2006 2010
00 01 02 03 04 05 06 07 08 09 10
Percen
t of p
atients
0
10
20
30
40
50
0-<2
2-<4
4-<6
6 months
Months after initiation
1 2 3 4 5 6
Mean w
kly EP
O dose (in
1,000
s)
5
10
15
20
25
30
1998
2002
2006 2010
00 01 02 03 04 05 06 07 08 09 10
Percen
t of p
atients
0
10
20
30
40
50
0-<1,200 mg
1,200-<2,100
2,100-<2,700
2,700+
97-98 99-00 01-02 03-04 05-06 07-08 09-10
Percen
t of p
atients
0
20
40
60
80
1004+ tests
3 tests
1 test
No tests
2 tests
97-98 99-00 01-02 03-04 05-06 07-08 09-10
% with
com
preh
ensive
mon
itorin
g
0
5
10
15
20
97-98 99-00 01-02 03-04 05-06 07-08 09-10
Percen
t of p
atients
0
20
40
60
80
1004+ tests
3 tests
1 test
No tests
2 tests
2005 2006 2007 2008 2009 2010
Percen
t of p
atients
0
20
40
60
80
AV fistula AV graft
Catheter w/maturing fistula
Catheter w/maturing graft
Catheter
